Viatris Quarterly Cash Flow Statement
NASDAQ: VTRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Viatris free cash flow
In the quarter ended Jun 30, 2026, Viatris generated $381.8 million of operating cash flow and spent $52.8 million on capital expenditures. That left free cash flow of $329.0 million, a free-cash-flow margin of 8.8% of revenue. Free cash flow was up 97.2% from the prior year's $166.8 million.
Viatris returned $150.0 million to shareholders through share repurchases, equal to 46% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Viatris cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -118.80M | 176.40M | — | -128.20M | -4.60M | -3.04B | — | 94.80M | -326.40M | 113.90M | — | 331.60M |
| Net Income growth (YoY) | — | — | — | -235.23% | — | -2770.76% | — | -71.41% | -223.64% | -49.31% | — | -6.41% |
| Depreciation & Amortization | 672.30M | 676.10M | 766.80M | 688.50M | 678.30M | 664.70M | 746.20M | 669.70M | 786.30M | 691.00M | 644.40M | 679.40M |
| Stock-Based Compensation | 38.70M | 48.20M | 49.40M | 36.00M | 37.10M | 55.20M | 32.30M | 32.40M | 34.70M | 46.70M | 55.80M | 43.10M |
| Change in Working Capital | -247.20M | -216.60M | 306.20M | 18.00M | -339.90M | 75.90M | 310.60M | -228.00M | -397.20M | -72.70M | 32.20M | -247.60M |
| Operating Cash Flow | 381.80M | 388.30M | 815.80M | 744.90M | 219.70M | 535.50M | 482.70M | 826.50M | 379.10M | 614.60M | 568.50M | 835.20M |
| Capital Expenditures | -52.80M | -39.90M | -196.50M | -86.80M | -52.90M | -42.60M | -140.40M | -77.00M | -58.80M | -49.80M | -165.50M | -95.90M |
| Investing Cash Flow | -51.60M | 277.40M | -211.20M | -98.90M | -52.50M | -65.10M | -168.70M | 1.75B | 375.80M | -154.30M | 26.70M | -54.90M |
| Share Repurchases | -150.00M | 0 | -85.10M | -67.90M | -175.00M | -175.40M | 0 | 0 | 0 | -250.00M | 0 | 0 |
| Debt Issued | — | — | — | — | — | — | — | — | — | — | 300.00K | 0 |
| Debt Repaid | — | — | -100.00K | 0 | — | — | -1.37B | -1.54B | -801.70M | 0 | -500.10M | 0 |
| Financing Cash Flow | -1.24B | -203.80M | -236.40M | -228.10M | -362.40M | -467.00M | -1.42B | -1.64B | -847.90M | -425.60M | -926.10M | -97.60M |
| Net Change in Cash | -915.70M | 457.70M | 344.50M | 435.70M | -188.50M | 20.20M | -1.14B | 961.60M | -97.40M | 22.30M | -318.20M | 680.40M |
| Free Cash Flow | 329.00M | 348.40M | 619.30M | 658.10M | 166.80M | 492.90M | 342.30M | 749.50M | 320.30M | 564.80M | 403.00M | 739.30M |
This table shows 12 quarterly periods of Viatris's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow VTRS's reporting calendar. What is a cash flow statement?